Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers
Reuters
Mon, 03/18/24 - 11:05 am
Tags:
AstraZeneca
,
inhalers
,
drug pricing
,
Boehringer Ingelheim
,
Airsupra
,
Bevespi Aerosphere
,
Breztri Aerosphere
,
COPD
AstraZeneca boosts rare disease portfolio with $1.05B Amolyt acquisition
BioSpace
Thu, 03/14/24 - 11:38 am
Tags:
AstraZeneca
,
M&A
,
Amolyt Pharma
,
eneboparatide
,
hypoparathyroidism
AstraZeneca kick-starts Phase III COPD trial for Breztri
Clinical Trials Arena
Thu, 03/14/24 - 11:21 am
Tags:
AstraZeneca
,
COPD
,
clinical trials
,
Breztri
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter
Stat
Thu, 03/7/24 - 05:35 pm
Tags:
Sanofi
,
AstraZeneca
,
Beyfortus
,
RSV
,
monoclonal antibodies
AstraZeneca to invest 650 million pounds in UK to boost 'pandemic preparedness'
Reuters
Wed, 03/6/24 - 11:18 am
Tags:
AstraZeneca
,
pandemic
,
UK
Surprise Enhertu rejection follows NICE process change
Pharmaphorum
Tue, 03/5/24 - 11:35 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
HER2-low breast cancer
,
Enhertu
,
NICE
,
UK
AstraZeneca’s drug pricing lawsuit dismissed by federal judge
BioPharma Dive
Mon, 03/4/24 - 11:46 pm
Tags:
AstraZeneca
,
drug pricing
,
legal
,
Medicare
,
Inflation Reduction Act
ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report
BioSpace
Fri, 03/1/24 - 11:52 am
Tags:
oncology
,
cancer
,
antibody-drug conjugate
,
Merck
,
AbbVie
,
Pfizer
,
AstraZeneca
AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure
Fierce Pharma
Tue, 02/27/24 - 11:16 am
Tags:
AstraZeneca
,
FibroGen
,
roxadustat
,
anemia
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
Tags:
oncology
,
clinical trials
,
Daiichi Sankyo
,
AstraZeneca
,
Enhertu
,
metastatic breast cancer
,
Gilead Sciences
,
Trodelvy
,
bladder cancer
,
GSK
,
Zejula
,
Jemperli
,
ovarian cancer
,
Roche
,
tiragolumab
,
Tecentriq
,
non-small cell lung cancer
,
Cue Biopharma
,
CUE-101
,
head and neck cancer
,
Elicio Therapeutics
,
ELI-002
,
solid tumors
What did Big Pharma CEOs get paid in 2023?
Medical Marketing and Media
Fri, 02/23/24 - 10:22 am
Tags:
Pharma CEOs
,
executive pay
,
AstraZeneca
,
Roche
,
Novartis
Daiichi Sankyo and AstraZeneca’s lung cancer antibody set for FDA review
Clinical Trials Arena
Tue, 02/20/24 - 11:30 am
Tags:
Daiichi Sankyo
,
AstraZeneca
,
FDA
,
Tagrisso
,
non-small cell lung cancer
AstraZeneca’s Evusheld fails to improve Covid outcomes in Phase III trial
Clinical Trials Arena
Tue, 02/20/24 - 11:01 am
Tags:
AstraZeneca
,
Evusheld
,
clinical trials
,
COVID-19
FDA approves AstraZeneca's Tagrisso-chemo combo
Reuters
Sun, 02/18/24 - 08:26 pm
Tags:
AstraZeneca
,
Tagrisso
,
lung cancer
,
FDA
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
Tags:
earnings
,
COVID-19
,
GLP-1 agonist
,
JNJ
,
Bristol Myers Squibb
,
Pfizer
,
AstraZeneca
,
Sanofi
,
Eli Lilly
,
Novo Nordisk
AstraZeneca’s year-end revenues rise but Wall Street remains unimpressed
Medical Marketing and Media
Thu, 02/8/24 - 11:23 am
Tags:
AstraZeneca
,
earnings
,
COVID-19
AstraZeneca to invest $300 million in US facility for cell therapies
Reuters
Tue, 02/6/24 - 11:38 pm
Tags:
AstraZeneca
,
cell therapy
AstraZeneca's phase 3 heart disease trial hits, teeing up Pfizer showdown in Japan
Fierce Biotech
Fri, 02/2/24 - 11:53 am
Tags:
AstraZeneca
,
Pfizer
,
acoramidis
,
Japan
,
clinical trials
,
cardiomyopathy
,
ATTR-CM
AstraZeneca Case Leads Off Busy Year of Challenges to Medicare Drug Pricing Law
BioSpace
Thu, 02/1/24 - 10:51 pm
Tags:
AstraZeneca
,
legal
,
Inflattion Reduction Act
,
Medicare
,
drug pricing
Sanofi expects RSV antibody to breach blockbuster status in 2024, even as supply hitch drags on
Fierce Pharma
Thu, 02/1/24 - 11:33 am
Tags:
Sanofi
,
RSV
,
AstraZeneca
,
Beyfortus
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.